Conversion of pancreas transplants to FK 506 from CsA.
Tesi
R J
RJ
Tulane University Medical Center, New Orleans, Louisiana, USA.
Bryer-Ash
M
M
Jaspan
J
J
Byer-Ashe M [corrected to Bryer-Ash
M ]
M]
D000328:Adult; D016572:Cyclosporine / Q000009:adverse effects / Q000627:therapeutic use*; D003922:Diabetes Mellitus, Type 1 / Q000601:surgery; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D016030:Kidney Transplantation; D008297:Male; D008875:Middle Aged; D016035:Pancreas Transplantation / Q000009:adverse effects / Q000379:methods* / Q000502:physiology; D012449:Safety; D016559:Tacrolimus / Q000009:adverse effects / Q000627:therapeutic use*
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D016559:Tacrolimus